期刊文献+

六味地黄丸制方考辨及抗肿瘤临证应用浅析 被引量:2

Discussion on Original Meaning and Anti-Tumor Clinical Application of Liuwei Dihuang Pill(六味地黄丸)
下载PDF
导出
摘要 六味地黄丸作为经典名方,被列为国家中医药管理局首批《古代经典名方目录》中,临床应用广泛。该方出自《小儿药证直诀》,主治肾怯失音,囟开不合,神不足,目中白睛多,面色白光白等症,其中蕴含深刻的中医学理论与思辨规律。作者通过考究钱氏制方之原,发现当前六味地黄丸作为主治“肾阴虚”的一般认知存在内涵泛化、缺失倾向。基于六味地黄丸原文,通过探讨其在精气、阴阳、五行、藏象、经络学说中的方证原义,并以此为基础阐发其在抗肿瘤临床应用中的具体思路,以期为经典名方六味地黄丸的推广及肿瘤临床决策提供新的理论支撑。 As a classic prescription,Liuwei Dihuang Pill(六味地黄丸)has been listed in the first batch of Ancient Classic Prescriptions Catalog of the State Administration of Traditional Chinese Medicine,and has been widely used in clinical practice.This recipe is derived from the Prescription for Children's Medicine Syndrome.It is mainly used to treat kidney phobia,aphasia,fontanel disjunction,mental insufficiency,white eyesand white complexion.It contains profound TCM theories and speculative laws.By studying the origin of Qian's formula,the author has found that the current general cognition of Liuwei Dihuang Pill as the main treatment of"kidney Yin deficiency"has a tendency of generalization and deletion.Based on the original text of Liuwei Dihuang Pill,this paper discussed the original meaning of the formula and syndrome in the theory of essence,Yin and Yang,five elements,viscera manifestations and meridians,and on this basis,it explained the specific ideas of its clinical application in anti-tumor,with a view to providing new theoretical support for the promotion ofLiuwei Dihuang Pill and clinical decision-making in cancer.
作者 姜晓晨 刘福栋 王桂彬 庞博 花宝金 JIANG Xiaochen;LIU Fudong;WANG Guibin;PANG Bo;HUA Baojin(Guang'anmen Hospital,China Academy of Chinese Medicine Science,Beijing 100053,China)
出处 《辽宁中医杂志》 CAS 2023年第2期80-83,共4页 Liaoning Journal of Traditional Chinese Medicine
基金 中国中医科学院科技创新工程创新团队专项(CI2021B009)。
关键词 六味地黄丸 方证 《小儿药证直诀》 肿瘤 Liuwei Dihuang Pill(六味地黄丸) prescriptions and syndrome Key to Therapeutics of Children's Diseases tumor
  • 相关文献

参考文献9

二级参考文献57

  • 1胡芬,向继洲.中药治疗血小板减少性紫癜的药理作用[J].医药导报,2005,24(6):480-482. 被引量:16
  • 2李景荣,卢喜珍,陈振江.六味地黄丸的补肾作用与微量元素的关系[J].中成药,1996,18(6):37-38. 被引量:11
  • 3王喜军.中药血清药物化学的研究动态及发展趋势[J].中国中药杂志,2006,31(10):789-792. 被引量:146
  • 4程能能 孙瑞元.新药药效统计及NDST程序[J].皖南医学院学报,1994,13:28-28.
  • 5陈奇.中药药理研究方法学[M].北京:人民卫生出版社,1992.413.
  • 6李向中.中药方剂的药理及临床应用[M].人民卫生出版社,1992.67.
  • 7王世中.免疫学技术[M].北京:科学出版社,1980.82.
  • 8The NCI Common Terminology Criteria for Adverse Events V3.0[EB/OL]. http://ctep. cancer. gov/protol Development/electronic_applications/docs/ctcaev3. pdf
  • 9Negrier S, Perol D, Menetrier-Caux C, et al. Interleukin-6 interleukin-10, and vascular metastatic renal cell carcinoma endothelial growth factor in prognostic value of interleukin-6 from the Groupe Francais d'Immunotherapie[J]. J Clin Oncol, 2004 22: 2371-2378.
  • 10Taneja SS, Pierce W, Figlin R, et al. Immunotherapy for renal carcinoma: the era of interleukin-2 based treatment[J]. Urology, 1995,45: 911-924.

共引文献185

同被引文献21

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部